Federal contract award
W81XWH19C0012
DHA 17.2 SBIR PHASE II MEDICAL R&D CONTRACT FOR PROPOSAL #H2-0383, TITLED: POINT OF CARE TEST FOR DISEASE SEVERITY AND RISK STRATIFICATION - ERMS 18234006
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN91 — OTHER MEDICAL - BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $2.1M |
| Current contract value | $2.1M |
| Potential contract value / ceiling | $2.1M |
| Start date | Mar 1, 2019 |
| Current end date | Jan 11, 2025 |
| Potential end date | Jan 11, 2025 |
| Latest award activity | Jan 25, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 25, 2024 | P00005 | $0 | LYNNTECH DHA SBIR PHASE II POINT OF CARE TEST FOR DISEASE SEVERITY AND RISK STRATIFICATION |
| Oct 26, 2022 | P00004 | $0 | PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/1/2022 AND COR CHANGE FOR LYNNTECH'S DHA SBIR PHASE II ENHANCEMENT MEDICAL R&D CONTRACT FOR "POINT OF CARE TEST FOR DISEASE SEVERITY AND RISK STRATIFICATION" |
| Aug 26, 2022 | P00003 | $1.1M | AWARD OF LYNNTECH'S DHA SBIR PHASE II ENHANCEMENT MEDICAL R&D CONTRACT FOR "POINT OF CARE TEST FOR DISEASE SEVERITY AND RISK STRATIFICATION" |
| Feb 26, 2021 | P00002 | $0 | DHA 2017.2 SBIR PHASE II MEDICAL R&D CONTRACT FOR PROPOSAL #H2-0383, TITLED: "POINT OF CARE TEST FOR DISEASE SEVERITY AND RISK STRATIFICATION" LOG 18234006 - ADD GFP SMART FORM AND 3-MONTH NO COST EXTENSION |
| Nov 20, 2020 | P00001 | $0 | DHA 2017.2 SBIR PHASE II MEDICAL R&D CONTRACT FOR PROPOSAL #H2-0383, TITLED: "POINT OF CARE TEST FOR DISEASE SEVERITY AND RISK STRATIFICATION" - LOG 18234006 - 889 COMPLIANCE AND ADMINISTRATIVE CHANGES |
| Feb 21, 2019 | 0 | $989.1K | DHA 17.2 SBIR PHASE II MEDICAL R&D CONTRACT FOR PROPOSAL #H2-0383, TITLED: POINT OF CARE TEST FOR DISEASE SEVERITY AND RISK STRATIFICATION - ERMS 18234006 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.